XML 79 R4.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 943 $ 1,201
Accounts and notes receivable, net 674 861
Inventories 1,079 1,147
Prepaid expenses and other 81 84
Total current assets 2,777 3,293
Property, plant, and equipment 9,413 8,992
Less: Accumulated depreciation (5,854) (5,701)
Property, plant, and equipment, net 3,559 3,291
Operating lease right-of-use assets 294  
Goodwill and other intangible assets, net 174 181
Investments in affiliates 162 160
Other assets 292 437
Total assets 7,258 7,362
Current liabilities:    
Accounts payable 923 1,137
Short-term and current maturities of long-term debt 134 13
Other accrued liabilities 484 559
Total current liabilities 1,541 1,709
Long-term debt, net 4,026 3,959
Operating lease liabilities 245  
Deferred income taxes 118 217
Other liabilities 633 457
Total liabilities 6,563 6,342
Commitments and contingent liabilities
Equity    
Common stock (par value $0.01 per share; 810,000,000 shares authorized; 188,893,478 shares issued and 163,574,243 shares outstanding at December 31, 2019; 187,204,567 shares issued and 170,780,474 shares outstanding at December 31, 2018) 2 2
Treasury stock, at cost (25,319,235 shares at December 31, 2019; 16,424,093 shares at December 31, 2018) (1,072) (750)
Additional paid-in capital 859 860
Retained earnings 1,249 1,466
Accumulated other comprehensive loss (349) (564)
Total Chemours stockholders’ equity 689 1,014
Non-controlling interests 6 6
Total equity 695 1,020
Total liabilities and equity $ 7,258 $ 7,362